GABAergic drugs inhibit amphetamine-induced distractibility in the rat

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 1, 1997, Pages 119-126

  Ågmo, Anders ^b   Medrano, Aida ^a   Garrido, Norma ^a   Alonso, Pilar ^a  

^a UNIVERSIDAD ANÁHUAC   (Mexico)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Amphetamine; Distractibility; GABA agonists

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE INHIBITOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; AMPHETAMINE; BACLOFEN; VALPROIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DISCRIMINATION LEARNING; EXPLORATORY BEHAVIOR; GABAERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

4-AMINOBUTYRATE TRANSAMINASE; AMPHETAMINE; ANIMALS; ATTENTION; BACLOFEN; CENTRAL NERVOUS SYSTEM STIMULANTS; ENZYME INHIBITORS; GABA AGENTS; GABA AGONISTS; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; VALPROIC ACID;

ANIMALIA;

EID: 0343923456     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00380-2     Document Type: Article

References (39)

1. Ågmo, A.; Belzung, C.: Interactions between dopamine and GABA in the control of ambulatory activity and neophobia in the mouse. Submitted.
2. A receptor. Psychopharmacology. 87:1985;51-54.
3. Ågmo A., Belzung C., Giordano M. Interactions between dopamine and GABA in the control of ambulatory activity. J. Neural Transm. 103:1996;925-934.
4. Ågmo A., Belzung C., Rodrguez C. A rat model of distractibility. effects of drugs modifying dopaminergic, noradrenergic and GABAergic neurotransmission J. Neural Transm. 104:1997;11-29.
5. Ågmo A., Paredes R., Fernández H. Differential effects of GABA transaminase inhibitors on sexual behavior, locomotor activity, and motor execution in the male rat. Pharmacol. Biochem. Behav. 28:1987;47-52.
6. Ågmo A., Pruneda R., Guzmán M., Gutiérrez M. GABAergic drugs and conflict behavior in the rat. Lack of similarities with the actions of benzodiazepines Naunyn-Schmiedeberg's Arch. Pharmacol. 344:1991;314-322.
7. Ahlenius S., Carlsson A., Engel J. Antagonism by baclofen of the d-amphetamine-induced disruption of a successive discrimination in the rat. J. Neural Transm. 36:1975;327-333.
8. Cott J., Engel J. Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine. Evidence for both pre- and post-synaptic inhibition of catecholamine systems J. Neural Transm. 40:1977;253-268.
9. Crider A., Solomon P., McMahon M. A. Disruption of selective attention in the rat following chronic d-amphetamine administration. Relationship to schizophrenic attention disorder Biol. Psychiat. 17:1982;351-361.
10. di Scala G., Martin-Iverson M. T., Phillips A. G., Fibiger H. C. The effects of progabide (SL76002) on locomotor activity and conditioned place preference induced by d-amphetamine. Eur. J. Pharmacol. 107:1985;271-274.
11. File S. E., Wardill A. G. Validity of head-dipping as a measure of exploration in a modified holeboard. Psychopharmacologia. 44:1975;53-59.
12. Gilman A. G. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8:1990;Pergamon Press, New York.
13. Grace A. A., Bunney B. S. Paradoxical GABA excitation of nigral dopaminergic cells. indirect mediation through reticulata inhibitory neurons Eur. J. Pharmacol. 59:1979;211-218.
14. Hughes R. N., Greig A. M. Effects of caffeine, methamphetamine and methylphenidate on reactions to novelty and activity in rats. Neuropharmacology. 15:1976;673-676.
15. Killcross A. S., Robbins T. W. Differential effects of intraaccumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology. 110:1993;479-489.
16. Klitenick M. A., DeWitte P., Kalivas P. W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA. an in vivo microdialysis study J. Neurosci. 12:1992;2623-2632.
17. Kumar R. Exploration and latent learning. Differential effects of dexamphetamine on components of exploratory behaviour in rats Psychopharmacologia. 16:1969;54-72.
18. Kumar R. Extinction of fear I. Effects of amylobarbitone and dexamphetamine given separately and in combination on fear and exploratory behaviour in rats Psychopharmacologia. 19:1971;163-187.
19. LeMoal M., Simon H. Mesocorticolimbic dopaminergic network. functional and regulatory roles Physiol. Rev. 71:1991;155-233.
20. Lloyd K. G., Worms P., Zivkovic B., Scatton B., Bartholini G. Interaction of GABA mimetics with nigro-striatal dopamine neurons. Brain Res. Bull. 5(Suppl. 2):1980;439-445.
21. Löscher W., Hörstermann D. Differential effects of vigabatrin, γ-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma. Naunyn-Schmiedeberg's Arch. Pharmacol. 349:1994;270-278.
22. Mazurkiewicz M., Sirviö J., Riekkinen P. Effects of single and repeated administration of vigabatrin on the performance of rats in a 5-choice serial reaction time task. Epilepsy Res. 13:1992;231-237.
23. McNeil D., Gower M., Szymanska I. Response of dopamine neurons in substantia nigra to muscimol. Brain Res. 154:1978;401-403.
24. Misslin R., Ropartz P. Effects of metamphetamine on novelty-seeking behaviour in mice. Psychopharmacology. 75:1981;39-43.
25. Paredes R. G., Ågmo A. Stereospecific actions of baclofen on sociosexual behavior, locomotor activity and motor execution. Psychopharmacology. 97:1989;358-364.
26. Robbins T., Iversen S. D. A dissociation of the effects of d-amphetamine on locomotor activity and exploration in rats. Psychopharmacologia. 28:1973;155-164.
27. Sandoval M. R. L., Palermo-Neto J. Effect of manipulation of the GABA system on dopamine-related behaviors. Braz. J. Med. Biol. Res. 28:1995;88-99.
28. B receptor agonists and antagonists. Brain Res. 630:1993;28-31.
29. Santiago M., Machado A., Cano J. In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex. differential modulation by baclofen Br. J. Pharmacol. 109:1993;814-818.
30. Scatton B., Zivkovic B., Dedek J., Lloyd K. G., Constrantinidis J., Tissot R., Bartholini G. γ-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas. J. Pharmacol. Exp. Ther. 220:1982;678-688.
31. Shephard R. A. Valproate enhances fluid consumption suppressed by shock or neophobia, but not by partial satiation or d-amphetamine, in rats. Life Sci. 43:1988;898-904.
32. Waldmeier P. C., Maitre L. Effects of baclofen on dopamine metabolism and interaction with neuroleptic effects. Eur. J. Pharmacol. 47:1978;191-200.
33. Waldmeier P. C., Feldtrauer J. J., Fehr B. Effects of baclofen on striatal dopamine and serotonin metabolism. Brain Res. Bull. 5(Suppl. 2):1980;545-548.
34. Waszczak B. L., Walters J. R. Intravenous GABA agonist administration stimulates firing of A10 dopaminergic neurons. Eur. J. Pharmacol. 66:1980;141-144.
35. Waszczak B. L., Eng N, Walters J. R. Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons. Brain Res. 188:1980;185-197.
36. Weiner I., Lubow R. E., Feldon J. Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol. Biochem. Behav. 30:1988;871-878.
37. B and NMDA receptor agonists on medial forebrain bundle self-stimulation. Behav. Brain. Res. 70:1995;31-36.
38. Wise R. A., Rompré P. P. Brain dopamine and reward. Annu. Rev. Psychol. 40:1989;191-225.
39. Yoshida M., Yokoo H., Tanaka T., Emoto H., Tanaka M. Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat. Brain Res. 636:1994;111-114.